Biogen Inc (BIIB)

283.63
-3.89(-1.35%)
After Hours
283.50
-0.13(-0.05%)
- Real-time Data
  • Volume:
    758,195
  • Day's Range:
    282.52 - 291.10
  • 52 wk Range:
    187.16 - 311.88
Earnings results expected in 10 days

Biogen will announce its quarterly financial results in 10 days. Traders should take this into account as the share price often fluctuates around this time period.

BIIB Overview

Prev. Close
287.52
Day's Range
282.52-291.1
Revenue
7.77B
Open
288.57
52 wk Range
187.16-311.88
EPS
19.62
Volume
758,195
Market Cap
40.84B
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
1,195,211
P/E Ratio
14.48
Beta
0.202
1-Year Change
28.03%
Shares Outstanding
144,001,404
Next Earnings Date
14 Feb 2023
What is your sentiment on Biogen?
or
Market is currently closed. Voting is open during market hours.

Biogen Inc News

Biogen Inc Analysis

Biogen Inc Company Profile

Biogen Inc Company Profile

Employees
9610

Biogen Inc. is a global biopharmaceutical company. It is focused on discovering, developing and delivering therapies for people living with serious neurological and neurodegenerative diseases as well as related therapeutic adjacencies. It has a portfolio of medicines to treat multiple sclerosis (MS), spinal muscular atrophy (SMA) and Alzheimer's disease. Its marketed products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the treatment of MS; SPINRAZA for the treatment of SMA; ADUHELM for the treatment of Alzheimer's disease; and FUMADERM for the treatment of severe plaque psoriasis. It also has a collaboration agreement with Genentech, Inc. (Genentech), a member of the Roche Group, with respect to RITUXAN for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL) and other conditions; RITUXAN HYCELA for the treatment of non-Hodgkin's lymphoma and CLL; GAZYVA; OCREVUS; and other potential anti-CD20 therapies, including mosunetuzumab.

Read More

Analyst Price Target

Average323.12 (+13.92% Upside)
High402.00
Low249.00
Price283.63
No. of Analysts26
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts Consensus

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellSellStrong SellSellBuy
Technical IndicatorsNeutralStrong SellStrong SellStrong SellStrong Buy
SummarySellStrong SellStrong SellStrong SellStrong Buy